Matches in Wikidata for { <http://www.wikidata.org/entity/Q61938110> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q61938110 description "assaig clínic" @default.
- Q61938110 description "clinical trial" @default.
- Q61938110 description "clinical trial" @default.
- Q61938110 description "clinical trial" @default.
- Q61938110 description "clinical trial" @default.
- Q61938110 description "ensaio clínico" @default.
- Q61938110 description "ensayo clínico" @default.
- Q61938110 description "ensayu clínicu" @default.
- Q61938110 description "essai clinique" @default.
- Q61938110 description "klinisch onderzoek" @default.
- Q61938110 description "клінічне випробування" @default.
- Q61938110 description "կլինիկական փորձարկում" @default.
- Q61938110 description "临床试验" @default.
- Q61938110 name "Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes" @default.
- Q61938110 type Item @default.
- Q61938110 label "Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes" @default.
- Q61938110 prefLabel "Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes" @default.
- Q61938110 P1050 Q61938110-531B6405-B875-4329-AB45-5C72E639A88B @default.
- Q61938110 P1132 Q61938110-981CDDC5-7155-4DA8-81E9-1426F5E24007 @default.
- Q61938110 P1476 Q61938110-B6C5534F-F29A-4BB8-AF39-B771E8BEA504 @default.
- Q61938110 P17 Q61938110-576CDD88-65BA-47B2-8742-6BF3CE123A85 @default.
- Q61938110 P17 Q61938110-6150289A-8263-4930-8B42-AF260A2660A5 @default.
- Q61938110 P17 Q61938110-9B2313C5-09B4-4B92-8174-EA824EA6314B @default.
- Q61938110 P17 Q61938110-9EB0EB04-EACF-484A-8E95-265D272EA65B @default.
- Q61938110 P17 Q61938110-B3122DD4-CDD6-47F9-88D0-31FE2AD6AF0C @default.
- Q61938110 P17 Q61938110-B4A9504A-1D4C-42CC-A40F-7EBD474699DE @default.
- Q61938110 P17 Q61938110-DCFB2DF2-E592-4329-B967-45784A94FF75 @default.
- Q61938110 P1813 Q61938110-EF1A3264-0E27-4A97-9E47-C607B1AEE9D0 @default.
- Q61938110 P2899 Q61938110-EE068866-DE9F-4EAA-B665-7EE6F6AC324B @default.
- Q61938110 P3098 Q61938110-4AE417DF-75C1-499E-BF1A-40D6B9281CED @default.
- Q61938110 P31 Q61938110-BCB07F5A-4D2C-46D5-8D1F-332D88E39E1D @default.
- Q61938110 P4844 Q61938110-3FF7DCF0-01B5-46A4-8937-8EC836E937E9 @default.
- Q61938110 P580 Q61938110-A38F18F3-3BE8-4C43-A1D1-876BFF99102B @default.
- Q61938110 P582 Q61938110-595B3DB7-2135-4134-A96A-F172B88998AA @default.
- Q61938110 P6099 Q61938110-AE86298F-2111-487C-97FC-0A2B38DE12FA @default.
- Q61938110 P6153 Q61938110-14744358-EF32-4C11-9081-47473BE41C83 @default.
- Q61938110 P8005 Q61938110-D98CB130-CA7E-463C-B1E2-905964CE1664 @default.
- Q61938110 P8363 Q61938110-691142D5-D54C-42BD-8BAD-E91D2AB9FECD @default.
- Q61938110 P1050 Q12206 @default.
- Q61938110 P1132 "+467" @default.
- Q61938110 P1476 "A 26-week Randomised, Confirmatory, Controlled, Open Label, Multicentre, Multinational Treat-to-target Trial Comparing the Efficacy and Safety of SIBA 200 U/ml Three Times Weekly Injected in the Evening and Insulin Glargine Once Daily in a Population of Insulin naïve Subjects With Type 2 Diabetes Mellitus Currently Treated With OADs Qualifying for Intensified Treatment (BEGIN™: EASY™)" @default.
- Q61938110 P17 Q142 @default.
- Q61938110 P17 Q16 @default.
- Q61938110 P17 Q218 @default.
- Q61938110 P17 Q219 @default.
- Q61938110 P17 Q28 @default.
- Q61938110 P17 Q30 @default.
- Q61938110 P17 Q55 @default.
- Q61938110 P1813 "BEGIN™" @default.
- Q61938110 P2899 "+18" @default.
- Q61938110 P3098 "NCT01076647" @default.
- Q61938110 P31 Q30612 @default.
- Q61938110 P4844 Q417317 @default.
- Q61938110 P580 "2010-03-01T00:00:00Z" @default.
- Q61938110 P582 "2010-12-01T00:00:00Z" @default.
- Q61938110 P6099 Q42824827 @default.
- Q61938110 P6153 Q818846 @default.
- Q61938110 P8005 Q76651189 @default.
- Q61938110 P8363 Q78089383 @default.